CEBPB, TP53, FOXO1, SFPQ, etc. are top upstream regulators, which are more dominant in NSC lung cancer-MSCs than controls (Supplementary Table 2) (Figure 1D; Supplementary Table 3). This evidence concerns the gene TP53 and lung cancer.